WilliamTseMDFACP, MBA

PubMed

• 27 citations
  Peripheral blood stem cell mobilization in multiple myeloma patients treat in the novel therapy‐era with plerixafor and G‐CSF has superior efficacy but significantly h...
  Lubna N Chaudhary, Farrukh T. Awan, Aaron Cumpston, Sonia Leadmon, Kathy Watkins
  Journal of Clinical Apheresis. 2013-10-01
• 34 citations
  Pathobiological Pseudohypoxia as a Putative Mechanism Underlying Myelodysplastic Syndromes
  Yoshihiro Hayashi, Yue Zhang, Asumi Yokota, Xiaomei Yan, Jinqin Liu
  Cancer Discovery. 2018-11-01
• 61 citations
  RNAi-mediated knockdown of Notch-1 leads to cell growth inhibition and enhanced chemosensitivity in human breast cancer
  Shaolei Zang, Feng Chen, Jianjian Dai, Dongmei Guo, William Tse
  Oncology Reports. 2010-04-01

Journal Articles

• Extra-pleural Pneumonectomy in the setting of tri-modality therapy for patients with Malignant mesothelioma  
  Alexander Ch, Sijin Wen, Nam Nguyen, Geraldine Jacobson, Scot Remick, William Tse and Zhongxing Liao, Chin J Cancer Res, 4/1/2013
• Regulation of Apoptosis by Bcl-2 Cysteine Oxidation in Human Lung Epithelial Cells  
  Luanpitpong S, Chanvorachote P, Stehlik C, Tse W, Callery PS, Wang L, Rojanasakul Y, Mol Biol Cell, 3/1/2013
• Th17 related cytokines in acute myeloid leukemia  
  Li P, Ji M, Park J, Bunting KD, Ji C, and Tse W, Front Biosci, 6/1/2012
• Prospective study of one- vs two-unit umb`ilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies. Bone Ma...  
  Kindwall-Keller TL, Hegerfeldt Y, Meyerson HJ, Margevicius S, Fu P, van Heeckeren W, Lazarus HM, Cooper BW, Gerson SL, Barr P, Tse WW, Curtis C, Fanning LR, Creger RJ,..., Bone Marrow Transplant, 10/17/2011
• Carbon Nanotubes Induce Malignant Transformation and Tumorigenesis of Human Lung Epithelial Cells  
  Wang L, Luanpitpong S, Castranova V, Tse W, Lu Y, Pongrakhananon V, Rojanasakul Y, Nano Lett, 7/13/2011
• Mir-29b regulates expression of AF1q, an MLL fusion partner, and low miR-29b expression associates with adverse cytogenetics and poor overall survival in AML  
  Xiong Y, Li Z, Ji M, Park J, Tan AC, Bemis L, Bunting KD & Tse W, Br J Haematol, 6/1/2011
• Molecular diagnosis and targeted therapy of a pediatric chronic eosinophilic leukemia patient carrying TPM3-PDGFRB fusion  
  Li Z, Yang R, Zhao J, Yuan R, Lu Q, Li Q, and Tse W, Pediatric Blood & Cancer, 3/1/2011
• Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based re...  
  Hamadani M, Craig M, Phillips GS, Abraham J, Tse W, Cumpston A, Gibson L, Remick SC, Bunner P, Leadmon S, Elder P, Hofmeister C, Penza S, Efebera Y, Andritsos L, Garzo..., Hematol Oncol, 2/28/2011
• Securinine, a Myeloid Differentiation Agent with Therapeutic Potential for AML  
  Gupta K, Chakrabarti A, Rana S, Ramdeo R, Roth BL, Agarwal ML, Tse W, Agarwal MK, Wald DN, PLoS ONE, 1/1/2011
• Effective targeting of STAT5-mediated survival in myeloproliferative neoplasms using ABT-737 combined with rapamycin  
  Li GQ, Miskimen K, Wang ZQ, Tse W, Bunting KD, Leukemia, 8/1/2010
• RNAi-mediated knockdown of Notch-1 leads to cell growth inhibition and enhanced chemosensitivity in human breast cancer  
  Zang S, Chen F, Dai J, Guo D, Tse W, Qu X, Ma D, Ji C, Oncol Rep, 4/23/2010
• Phase I study of temozolomide and laromustine (VNP40101M) in patients with relapsed or refractory leukemia  
  Rizzieri D, LoRusso S, Tse W, Khan K, Advani A, Moore J, Karsten V, Cahill A, Gerson SL, Clinical Lymphoma, Myeloma & Leukemia, 4/1/2010
• STAT5 requires the N-domain for suppression of miR15/16, induction of bcl-2, and survival signaling in myeloproliferative disease  
  Li GQ, Miskimen K, Wang ZQ, Xie XY, Ryan J, Tse W, Moriggl R, and Bunting KD, Blood, 2/18/2010
• Non-redundant role for Gab2 and Stat5 in promoting hematopoietic stem cell survival and self-renewal  
  Li GQ, Wang ZQ, Miskimen K, Zhang Y, Tse W, Bunting KD, PLoS ONE, 2/10/2010
• Determination of 6-benzylthioinosine in mouse and human plasma by liquid chromatography-tandem mass spectrometry  
  Li L, Xu Y, Wald DN, and Tse W, J Chromatogr B Analyt Tech Biomed Life Sci, 11/15/2009
• Molecular Risk Classification for Adult Acute Myeloid Leukemia with Normal Cytogenetics  
  Tara Gregory, David Wald, Yin Xiong, and William Tse, J Hematol Oncol, 6/2/2009
• Conditional deletion of STAT5 in adult mouse hematopoietic stem cells causes loss of quiescence and permits efficient non-ablative stem cell replacement  
  Wang ZQ, Li GQ, Tse W, and Bunting KD, Blood, 5/14/2009
• Elevated AF1q Expression is a Poor Prognostic Marker for Adult Acute Myeloid Leukemia Patients with Normal Cytogenetics  
  Strunk CJ, Platzbecker U, Thiede C, Schaich M, Illmer T, Kang Z, Leahy P, Li C, Xie XY, Laughlin MJ, Lazarus HM, Gerson SL, Bunting KD, Ehninger G, Tse W, Am J Hematol, 5/1/2009
• Umbilical cord blood transplantation  
  Wagner JE, Brunstein C, Tse W, Laughlin M, Cancer Treat Res, 1/1/2009
• New insights of umbilical cord blood transplantation  
  Tse W, Bunting KD, and Laughlin MJ, Curr Opin Hematol, 7/1/2008
• Identification and preclinical characterization of novel Acute Myeloid Leukemia differentiation-inducing compounds  
  Wald D, Vermaat J, Kang Z, Roth BR, Tse W, Cancer Res, 6/1/2008
• Hematopoiesis in mice is extremely resilient to wide variation in TIMP/MMP balance  
  Haviernik P, Diaz MT, Haviernikova E, Tse W, Stetler-Stevenson WG, and Bunting KD, Blood Cells Mol Dis, 5/16/2008
• Umbilical cord blood transplantation in adult acute myeloid leukemia patients  
  Tse W, Zang SL, Bunting KD, and Laughlin MJ, Bone Marrow Transplant, 3/1/2008
• Genetic Abnormalities in Acute Myeloid Leukemia with normal cytogenetics  
  Wald D, Vermaat J, Tse W, Current Hematologic Malignancy Reports, 1/1/2008
• Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults  
  Van Heeckeren WJ, Fanning LR, Meyerson HJ, Fu P, Lazarus HM, Cooper BW, Tse W, Kindwall-Keller TL, Jaroscak J, Finney MR, Fox RM, Solchaga L, Forster M, Creger RJ, Lau..., Br J Haematol, 11/1/2007
• Join now to see all

Books/Book Chapters

• Hematopoietic Stem Cell Protocol 
  Chapter: The expanding tool kit for hematopoietic stem cell research 
  William Tse and Kevin BuntingEditors: Kevin Bunting.Human Press2007
• Hematology: Basic Principals and Practice 
  Chapter: Hematopoietic stem cell transplantation for acquired nonmalignant diseases and myelodysplastic syndrome 
  William Tse and Joachim H. DeegEditors: Hoffman R et al.Edition 4th,

Lectures

• Oncogene section 
  American Society of Hematology Annual Meeting, Atlanta, GA - 12/1/2012
• The AF1q/CD44 signaling and cancer metastasis 
  Medical University of Vienna, Austria; Medical University of Saltsburg, Austria - 6/25/2012
• Allogeneic stem cell transplantation outcome study 
  American Society of Hematology Annual Meeting, San Diego, CA - 12/1/2011
• Clinical Significance of AF1q Expression in Hematologic Malignancy and Solid Cancers 
  Generon Corporation Ltd, Shanghai, P R China - 5/1/2011
• 6-BT, a Novel myeloid leukemia differentiation inducer targeting malignant glioblastoma stem cells 
  14th Annual Meeting of the Translational Research Cancer Centers Consortium: Seven Springs, PA - 2/25/2011
• Developing differential induction agents that target cancer stem cells 
  Aflac Cancer Center and Blood Disorders Service, Emory University School of Medicine Special Lecture - 12/2/2010
• Biological Function and Clinical Application of the AF1q Gene in Acute Myeloid Leukemia 
  Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria Special Lecture - 12/9/2009
• Gab 2 signaling and chemo-resistance in cancer therapy 
  Chinese Academy of Medical Sciences, Special Invited Lecture - 6/16/2009
• Searching for Differentiation Induction Agents for AML 
  Medical University of South Carolina Cancer Center Grand Round, Title - 6/10/2009
• Current Trends in Myelodysplastic Syndrome 
  Shandong University School of Medicine Special Invited Lcture - 6/1/2009
• ASH 2008 Update in Low grade Lymphoma and T-cell Lymphoma 
  ASH Update, New York Medical College, White Plain, NY - 1/31/2009
• Biology and Clinical Management of Myelodysplastic Syndrome 
  College of Life Sciences and College of Medicine, Xiamen University, P R China - 7/8/2008
• ASH 2007 Update in Acute Leukemias 
  ASH Update, Cleveland Clinical Foundation, Cleveland, Ohio - 1/19/2008
• Biological and Clinical Study the AF1q gene in Acute Myeloid Leukemia 
  Mary Babb Randolph Cancer Center, University of West Virginia Cancer Center Grand Round - 6/1/2007
• Molecular Risk Classification for Acute Myeloid Leukemia with Normal Cytogenetics 
  University of California at San Francisco Cancer Center BMT/Hematologic Malignancies Section Grand - 4/1/2007
• AF1q Over expression is Adverse Prognostic Marker for Acute Myeloid Leukemia with Normal Cytogenetics 
  Leukemia Committee and Laboratory Science Subcommittee, Eastern Cooperative Oncology Group (ECOG) - 10/1/2006
• Unfolding the biological functions of the Mll fusion partner AF1q/Mllt11 in cancers 
  Karmanos Cancer Institute, Wayne State University School of Medicine, Clinical Immunotherapy Progra
• Join now to see all